Significant responses to platinum-based chemotherapy in renal medullary carcinoma
- PMID: 15602719
- DOI: 10.1002/pbc.20292
Significant responses to platinum-based chemotherapy in renal medullary carcinoma
Abstract
Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.
Comment in
-
Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.Pediatr Blood Cancer. 2006 Aug;47(2):228. doi: 10.1002/pbc.20780. Pediatr Blood Cancer. 2006. PMID: 16514612 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical